FKRP and muscular disease: Our data show robust engraftment that is accompanied by restoration of α-DG functional glycosylation and amelioration of disease phenotypes, thus supporting the therapeutic benefit of cell transplantation for LGMD2I and potentially other FKRP-associated muscle disorders.